Integrating Sentinel into Routine Regulatory Drug Review: A Snapshot of the First Year

Basic Details
Date
Friday, August 25, 2017
Type
Presentation
Medical Product
aripiprazole
combined oral contraceptive (COC)
gadolinium-based contrast agent (GBCA)
olanzapine
Ranexa
ranolazine
risperidone
Health Outcome(s)
seizure
stroke
venous thromboembolism (VTE)
Presenter(s)

Michael D. Nguyen, Judith C. Maro, Lockwood G. Taylor, David Moeny, Efe Eworuke, Steven Bird